Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706014 · ClinicalTrials.gov registry record · NA
Innovative Family Prevention With Latino Siblings in Disadvantaged Settings
A NA study of Promotion of Positive Sibling Relationships, sponsored by Harvard University.
- Active
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT03706014 is a NA study of Promotion of Positive Sibling Relationships that is active but no longer recruiting, run by Harvard University. The registered enrollment target is 270 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03706014, a NA study of Promotion of Positive Sibling Relationships, is active but no longer recruiting, sponsored by Harvard University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study is a randomized intervention trial that tests the efficacy of a family-focused sibling relationship promotion program. The study includes a treatment group and a contact-equivalent attention control condition with 288 sibling dyads and data collection with target parents, target sibling dyads, and teachers at three time points (pre-test, post-test, and 18-month follow-up). Data will be collected using a three-cohort design with 96 families in each of the three cohorts.
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL SIBS Program
Study Locations (1)
Arizona
- Arizona State University - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2018-09-29 |
| Est. Completion | 2025-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03706014
The ClinicalTrials.gov registry entry for NCT03706014 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Promotion of Positive Sibling Relationships appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03706014 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03706014 about?
NCT03706014 is a clinical study titled "Innovative Family Prevention With Latino Siblings in Disadvantaged Settings". The current study is a randomized intervention trial that tests the efficacy of a family-focused sibling relationship promotion program. The study includes a treatment group and a contact-equivalent attention control condition with 288 sibling dyads and data collection with target parents, target si...
What is the current status of trial NCT03706014?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2018-09-29. Estimated completion is 2025-12-15.
What conditions does trial NCT03706014 study?
This clinical trial studies the following conditions: Promotion of Positive Sibling Relationships.
What interventions are being tested in trial NCT03706014?
The interventions under investigation include: Control (BEHAVIORAL), SIBS Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03706014?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03706014 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.